Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Nasopharyngeal Carcinoma × Medicare Part B × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Head & Neck 1 Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Sarcoma 1 Nasopharyngeal Carcinoma 1 Esophageal Neoplasms 1 Chondrosarcoma 1 Carcinoma, Hepatocellular 1

Interventions

toripalimab 2 Ipilimumab 2 Specimen Handling 1 Nivolumab 1 Medicare Part B 1 Magnetic Resonance Spectroscopy 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03474640 2024-11-22

Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies

TopAlliance Biosciences

Phase 1 Completed

184 enrolled 20 charts

GastrointestinalHead & NeckSarcoma

Nasopharyngeal Carcinoma, Chondrosarcoma, Esophageal Neoplasms, Carcinoma, Hepatocellular, Sarcoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡